A nanoscale metal organic frameworks-based vaccine synergises with PD-1 blockade to potentiate anti-tumour immunity
Open Access
- 31 July 2020
- journal article
- research article
- Published by Springer Nature in Nature Communications
- Vol. 11 (1) , 1-15
Abstract
Checkpoint blockade therapy has provided noteworthy benefits in multiple cancers in recent years; however, its clinical benefits remain confined to 10–40% of patients with extremely high costs. Here, we design an ultrafast, low-temperature, and universal self-assembly route to integrate immunology-associated large molecules into metal-organic-framework (MOF)-gated mesoporous silica (MS) as cancer vaccines. Core MS nanoparticles, acting as an intrinsic immunopotentiator, provide the niche, void, and space to accommodate antigens, soluble immunopotentiators, and so on, whereas the MOF gatekeeper protects the interiors from robust and off-target release. A combination of MOF-gated MS cancer vaccines with systemic programmed cell death 1 (PD-1) blockade therapy generates synergistic effects that potentiate antitumour immunity and reduce the effective dose of an anti-PD-1 antibody to as low as 1/10 of that for PD-1 blockade monotherapy in E.G7-OVA tumour-bearing mice, with eliciting the robust adaptive OVA-specific CD8+ T-cell responses, reversing the immunosuppressive pathway and inducing durable tumour suppression.Keywords
Funding Information
- Nippon Sheet Glass Foundation for Materials Science and Engineering
- National Institute of Advanced Industrial Science and Technology (Edgerunner)
- MEXT | Japan Society for the Promotion of Science (17K01399, 26750162)
This publication has 40 references indexed in Scilit:
- Nanoscale metal-organic frameworks enhance radiotherapy to potentiate checkpoint blockade immunotherapyNature Communications, 2018
- Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: American Society of Clinical Oncology Clinical Practice GuidelineJournal of Clinical Oncology, 2018
- Material aid for vaccinesNature Materials, 2018
- Core-shell nanoscale coordination polymers combine chemotherapy and photodynamic therapy to potentiate checkpoint blockade cancer immunotherapyNature Communications, 2016
- Melanoma Cell-Intrinsic PD-1 Receptor Functions Promote Tumor GrowthCell, 2015
- T cell exclusion, immune privilege, and the tumor microenvironmentScience, 2015
- Immunoengineering: How Nanotechnology Can Enhance Cancer ImmunotherapyCell, 2015
- Injectable, spontaneously assembling, inorganic scaffolds modulate immune cells in vivo and increase vaccine efficacyNature Biotechnology, 2014
- Cross-presentation by dendritic cellsNature Reviews Immunology, 2012
- Immunosuppressive networks in the tumour environment and their therapeutic relevanceNature Reviews Cancer, 2005